4,7,10,13,16,19-docosahexaenoic acid [C22:6w3]; cervonic acid (DHA, Doconexent)

From Aaushi
Jump to navigation Jump to search

Function

Structure

  • [C22:6w3]

Expression

 %   phospholipid                tissue             species
37   phosphatidylserine          gray matter        human
24   phosphatidylethanolamine    gray matter        human
 6   phosphatidylserine          white matter       human
 3   phosphatidylethanolamine    white matter       human
34   phosphatidylserine          synaptic membrane  rat
32   phosphatidylethanolamine    synaptic membrane  rat
43   phosphatidylethanolamine    synaptic membrane  mouse
37   phosphatidylserine          synaptic vesicle   rat
31   phosphatidylethanolamine    synaptic vesicle   rat

Pathology

Pharmacology

Laboratory

Notes

  • present in fish oils in varying amounts
  • not found in plant sources excepting certain seaweeds
  • Pharmaceutical/Neutraceutical: Lipil (Expecta) 200 mg[9]

More general terms

Additional terms

Component of

References

  1. de Urquiza AM et al Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science. 2000 Dec 15;290(5499):2140-4. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11118147
  2. Salem, M et al, Docosahexenoic acid: membrane function and metabolism. in: Health Effects of Polyunsaturated Fatty Acids in Seafoods, Academic Press, 1986
  3. 3.0 3.1 Shaikh SR, Cherezov V, Caffrey M, Stillwell W, Wassall SR. Interaction of cholesterol with a docosahexaenoic acid- containing phosphatidylethanolamine: trigger for microdomain/ raft formation? Biochemistry. 2003 Oct 21;42(41):12028-37 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14556634
  4. 4.0 4.1 Davis BC, Kris-Etherton PM. Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications. Am J Clin Nutr. 2003 Sep;78(3 Suppl):640S-646S. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12936959
  5. 5.0 5.1 James MJ, Ursin VM, Cleland LG. Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am J Clin Nutr. 2003 May;77(5):1140-5. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12716664
  6. Tully AM, Roche HM, Doyle R, Fallon C, Bruce I, Lawlor B, Coakley D, Gibney MJ. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr. 2003 Apr;89(4):483-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12654166
  7. Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, Ishibashi Y, Oka J, Shido O. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem. 2002 Jun;81(5):1084-91. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12065621
  8. Kyle DJ, Schaefer E, Patton G, Beiser A. Low serum docosahexaenoic acid is a significant risk factor for Alzheimer's dementia. Lipids. 1999;34 Suppl:S245. PMID: https://www.ncbi.nlm.nih.gov/pubmed/10419166
  9. 9.0 9.1 Mead Johnson, Evansville IL 47721 http:://ww.ExpectLIPIL.com
  10. 10.0 10.1 Makrides M et al Effect of DHA Supplementation During Pregnancy on Maternal Depression and Neurodevelopment of Young Children JAMA. 2010;304(15):1675-1683. doi:10.1001/jama.2010.1507 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/20959577 <Internet> http://jama.ama-assn.org/cgi/content/full/304/15/1675
  11. 11.0 11.1 Brasky TM et al Serum Phospholipid Fatty Acids and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial Am. J. Epidemiol April 24, 2011 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21518693 <Internet> http://aje.oxfordjournals.org/content/early/2011/04/19/aje.kwr027.abstract
  12. 12.0 12.1 Office of Dietary Supplements, National Institutes of Health Nutritional Research Series: Advancing the Role of Evidence- based Reviews in Nutrition Research and Applications Volume 4: Effects of Eicosapentanoic Acid and Docosahexanoic Acid on Mortality Across Diverse Settings: Systematic Review and Meta-Analysis of Randomized Trials and Prospective Cohorts http://www.ahrq.gov/clinic/tp/nutritn4tp.htm
  13. 13.0 13.1 Gould JF, Treyvaud K, Yelland LN et al. Seven-year follow-up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA 2017 Mar 21; 317:1173 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28324081 <Internet> http://jamanetwork.com/journals/jama/article-abstract/2612605
  14. 14.0 14.1 Collins CT et al. Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants. N Engl J Med 2017 Mar 30; 376:1245 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28355511 <Internet> http://www.nejm.org/doi/10.1056/NEJMoa1611942
  15. 15.0 15.1 15.2 George J Omega-3 Supplements Show Benefit in APOE4 Carriers. Trial finds DHA can penetrate the brain before dementia onset. MedPage Today November 1, 2024 https://www.medpagetoday.com/meetingcoverage/ctad/112713

Database